$164 Million is the total value of HealthInvest Partners AB's 44 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 24.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $17,647,125 | +146.5% | 133,741 | +103.6% | 10.74% | +91.6% |
| LLY | Buy | ELI LILLY & CO | $16,164,453 | +75.5% | 20,778 | +31.5% | 9.84% | +36.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $11,398,383 | +17.6% | 23,041 | +25.2% | 6.94% | -8.6% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $8,826,255 | +45.7% | 15,186 | +33.0% | 5.37% | +13.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $5,996,762 | +260.7% | 43,480 | +244.6% | 3.65% | +180.5% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $5,708,600 | +21.9% | 170,000 | +17.2% | 3.47% | -5.3% |
| SYK | Buy | STRYKER CORPORATION | $5,423,162 | +41.5% | 15,154 | +18.4% | 3.30% | +10.0% |
| AMGN | Buy | AMGEN INC | $5,371,089 | +16.4% | 18,891 | +17.9% | 3.27% | -9.5% |
| ABBV | Buy | ABBVIE INC | $5,343,907 | +62.7% | 29,346 | +38.5% | 3.25% | +26.4% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $5,301,194 | +41.5% | 77,401 | +19.4% | 3.22% | +10.0% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $5,190,709 | +48.5% | 5,393 | +35.5% | 3.16% | +15.4% |
| ABC | Sell | CENCORA INC | $4,963,314 | -37.9% | 20,426 | -47.5% | 3.02% | -51.7% |
| MOH | Sell | MOLINA HEALTHCARE INC | $4,929,960 | +9.2% | 12,000 | -4.0% | 3.00% | -15.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $4,721,423 | +27.1% | 11,295 | +23.7% | 2.87% | -1.2% |
| OPCH | Buy | OPTION CARE HEALTH INC | $4,457,298 | +255.4% | 132,895 | +257.0% | 2.71% | +176.2% |
| ANTM | Sell | ELEVANCE HEALTH INC | $3,837,196 | -14.3% | 7,400 | -22.1% | 2.34% | -33.4% |
| GILD | Sell | GILEAD SCIENCES INC | $3,809,000 | -52.5% | 52,000 | -47.5% | 2.32% | -63.1% |
| DXCM | Buy | DEXCOM INC | $3,645,452 | +62.7% | 26,283 | +45.6% | 2.22% | +26.5% |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $3,089,760 | – | 123,000 | +100.0% | 1.88% | – |
| CAH | Sell | CARDINAL HEALTH INC | $3,077,250 | -36.4% | 27,500 | -42.7% | 1.87% | -50.6% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $2,972,176 | +330.0% | 252,307 | +418.0% | 1.81% | +234.2% |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $2,959,984 | +146.4% | 138,836 | +11.1% | 1.80% | +91.6% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $2,765,340 | +125.5% | 63,791 | +163.1% | 1.68% | +75.3% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $2,658,435 | +397.4% | 40,899 | +422.8% | 1.62% | +287.1% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $2,633,060 | +200.2% | 38,050 | +210.7% | 1.60% | +133.5% |
| IQV | Sell | IQVIA HLDGS INC | $2,543,568 | +6.3% | 10,058 | -2.7% | 1.55% | -17.4% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $2,367,499 | +49.2% | 24,775 | +19.0% | 1.44% | +15.9% |
| SWAV | Buy | SHOCKWAVE MED INC | $1,547,068 | +130.0% | 4,751 | +34.6% | 0.94% | +78.6% |
| New | CORBUS PHARMACEUTICALS HLDGS | $1,491,120 | – | 38,000 | +100.0% | 0.91% | – | |
| CABA | Buy | CABALETTA BIO INC | $1,322,832 | +177.5% | 77,540 | +269.2% | 0.80% | +115.8% |
| Buy | ARCELLX INC | $1,216,847 | +92.3% | 17,496 | +53.5% | 0.74% | +49.5% | |
| KRYS | KRYSTAL BIOTECH INC | $1,178,608 | +43.4% | 6,624 | 0.0% | 0.72% | +11.5% | |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $1,170,044 | +20.8% | 37,841 | +57.8% | 0.71% | -6.1% |
| EXAS | Buy | EXACT SCIENCES CORP | $1,113,247 | +23.8% | 16,120 | +32.6% | 0.68% | -3.8% |
| MRUS | MERUS N V | $1,095,355 | +63.7% | 24,325 | 0.0% | 0.67% | +27.1% | |
| INSP | Buy | INSPIRE MED SYS INC | $1,027,126 | +56.4% | 4,782 | +48.1% | 0.62% | +21.6% |
| CYTK | Buy | CYTOKINETICS INC | $981,540 | +0.2% | 14,000 | +19.3% | 0.60% | -22.2% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $945,055 | +61.4% | 3,539 | +39.8% | 0.58% | +25.5% |
| MGNX | New | MACROGENICS INC | $725,799 | – | 49,307 | +100.0% | 0.44% | – |
| AKRO | Buy | AKERO THERAPEUTICS INC | $617,152 | +71.3% | 24,432 | +58.3% | 0.38% | +33.3% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $614,681 | -0.9% | 96,345 | 0.0% | 0.37% | -23.0% | |
| New | NEWAMSTERDAM PHARMA COMPANYordinary shares | $529,618 | – | 22,394 | +100.0% | 0.32% | – | |
| MORF | MORPHIC HLDG INC | $526,310 | +21.9% | 14,952 | 0.0% | 0.32% | -5.3% | |
| MRSN | New | MERSANA THERAPEUTICS INC | $448,000 | – | 100,000 | +100.0% | 0.27% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -8,342 | -100.0% | -0.24% | – |
| Exit | AMBRX BIOPHARMA INC | $0 | – | -57,847 | -100.0% | -0.64% | – | |
| PFE | Exit | PFIZER INC | $0 | – | -42,820 | -100.0% | -0.96% | – |
| CI | Exit | THE CIGNA GROUP | $0 | – | -15,000 | -100.0% | -3.52% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -88,000 | -100.0% | -3.53% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -62,000 | -100.0% | -3.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-04-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 18 | Q1 2024 | 14.5% |
| CARDINAL HEALTH INC | 18 | Q2 2024 | 14.8% |
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ELEVANCE HEALTH INC | 14 | Q1 2024 | 14.3% |
| CENCORA INC | 13 | Q2 2024 | 17.1% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| BRISTOL-MYERS SQUIBB CO | 11 | Q4 2023 | 14.7% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.